IPG Investment Advisors’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$169K Buy
15,176
+3,400
+29% +$41.3K 0.02% 253
2026
Q1
$164K Hold
11,776
0.03% 230
2025
Q4
$169K Hold
11,776
0.03% 213
2025
Q3
$187K Sell
11,776
-439
-4% -$7.23K 0.03% 201
2025
Q2
$216K Hold
12,215
0.04% 160
2025
Q1
$255K Hold
12,215
0.06% 142
2024
Q4
$226K Hold
12,215
0.05% 148
2024
Q3
$239K Buy
12,215
+1,903
+18% +$37.9K 0.05% 143
2024
Q2
$202K Buy
+10,312
New +$196K 0.04% 161

Other funds holding BTAL

IPG Investment Advisors's BTAL Position: Q2 2026 in Review

IPG Investment Advisors increased its AGF US Market Neutral Anti-Beta Fund (BTAL) stake by 29% in Q2 2026, buying an estimated $41.3K and bringing the position to 15,176 shares worth $169K. The position accounts for 0.02% of the portfolio, ranked #253.

IPG Investment Advisors first reported a position in BTAL in Q2 2024 and has held it in 9 quarters since. The position peaked at $255K in Q1 2025. 93 funds tracked by Wall St. Rank hold BTAL as of Q2 2026.

  • IPG Investment Advisors held 15,176 shares of AGF US Market Neutral Anti-Beta Fund worth $169K as of Q2 2026.
  • IPG Investment Advisors bought 3,400 AGF US Market Neutral Anti-Beta Fund shares in Q2 2026, an estimated $41.3K.
  • AGF US Market Neutral Anti-Beta Fund made up 0.02% of IPG Investment Advisors's portfolio in Q2 2026, its #253 holding.
  • IPG Investment Advisors first reported a position in AGF US Market Neutral Anti-Beta Fund in Q2 2024 and has held it in 9 quarters since.
  • IPG Investment Advisors's AGF US Market Neutral Anti-Beta Fund position peaked at $255K in Q1 2025.
  • 93 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q2 2026.

Based on IPG Investment Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.